Citation 62726

LEONHARDT,K: ANKE,T: HILLEN-MASKE,E: STEGLICH,W:. (1987). 6-METHYLPURINE, 6-METHYL-9-BETA-D-RIBOFURANOSYLPURINE, AND 6-HYDROXYMETHYL-9-BETA-ALPHA-RIBOFURANOSYLPURINE AS ANTIVIRAL METABOLITES OF COLLYBIA MACULATA (BASIDIOMYCETES) [1].. 42(4)

Citation Details

Title6-METHYLPURINE, 6-METHYL-9-BETA-D-RIBOFURANOSYLPURINE, AND 6-HYDROXYMETHYL-9-BETA-ALPHA-RIBOFURANOSYLPURINE AS ANTIVIRAL METABOLITES OF COLLYBIA MACULATA (BASIDIOMYCETES) [1].
AuthorsLEONHARDT,K: ANKE,T: HILLEN-MASKE,E: STEGLICH,W:
Year1987
Volume42
Issue4

Summary

Year: 1987

Journal: Unknown

Organisms and Their Experiments (1)

Collybia maculata (TRICHOLOMATACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PURINE,6-METHYL:
None
2
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PURINE,6-METHYL:
ACTIVE
3
ADENOSINE DEAMINASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PURINE,6-METHYL:
INACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL:
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL:
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL:
ACTIVE
7Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
None
8
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
9
ADENOSINE DEAMINASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
WEAK ACTIVITY
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
None
14
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
15
ADENOSINE DEAMINASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PURINE,6-HYDROXY-METHYL: 9-BETA-D-RIBOFURANOSIDE
ACTIVE
Show SPARQL Queries (1)